Database for Clinical and Anamnestic Data in Pulmonary Hypertension

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedical University of Graz

About this trial

Pulmonary hypertension (PH) is defined as a pulmonary arterial mean pressure (meanPAP) ≥ 25 mmHg measured in the right heart catheterization.

There are different forms of PH defined in the classification of Dana Point 2008.

PH is diagnosed with right heart catheterization but there are other non invasive methods which can be used for screening like the echocardiography, stress echocardiography and cardio pulmonary exercise testing. In the diagnosis process and in the follow up of PH patients biomarkers like NTproBNP are helpful. There are no specific biomarkers for the disease which can make the diagnosis process easier and predict prognosis.

The systematic data collection in a data base provides better information about patients in daily routine and clinical studies as well as in the design of new studies.

Eligibility criteria

Qualifiers

patients with pulmonary hypertension

patients at risk for getting pulmonary hypertension

patients who have symptoms which my be due to pulmonary hypertension when we have their written informed consent.

Disqualifiers

patients without written informed consent

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

900 Participants
are grouped into 1 trial group

Sponsors and collaborators